Purdue Pharma launches no-profit treatment to reverse opioid overdose effects

Five months after the FDA approved Purdue Pharma’s opioid antagonist injection, nalmefene hydrochloride, the no-profit treatment is now available for use, according to a June 21 press release. 
Category: Channels | Featured | Pharmacy